|Title: ||Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery.|
|Citation: ||International Journal of Pharmaceutics, 298(2): 339-343|
|Publisher: ||Elsevier Science Direct|
|Journal: ||International Journal of Pharmaceutics|
|Issue Date: ||2005 |
|PubMed ID: ||15967607|
|Additional Links: ||http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T7W-4GFCPVT-1&_user=1644469&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000054077&_version=1&_urlVersion=0&_userid=1644469&md5=af750868585f0a5f9ff74c005d4e33a7|
|Abstract: ||The aim of this study was to further investigate the interactions between cholesterol (CH) and mixed bile salts (BS) (sodium cholate and sodium deoxycholate) and their suitability for drug and vaccine delivery. Insulin was used as a model protein to assess the ability of CH:BS vesicles to entrap a therapeutically relevant macromolecule. The association of protein (FITC-insulin) with the CH:BS structure was confirmed with fluorescence microscopy, and the overall morphology of the vesicles was examined with atomic force microscopy (AFM). Results demonstrate that the nature of the vesicles formed between CH and BS is dependent not only on the concentration of BS but also on the increasing CH concentration leading to CH crystal formation.|
|MeSH: ||Bile Acids and Salts|
Drug Delivery Systems
Microscopy, Atomic Force
|Appears in Collections: ||Pharmacy and Natural Products Research Group|
|Files in This Item:|
There are no files associated with this item.
All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.